1. Home
  2. CCTG vs PPCB Comparison

CCTG vs PPCB Comparison

Compare CCTG & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

HOLD

Current Price

$0.59

Market Cap

1.8M

Sector

N/A

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

HOLD

Current Price

$0.11

Market Cap

1.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCTG
PPCB
Founded
1993
2007
Country
Hong Kong
Australia
Employees
N/A
2
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CCTG
PPCB
Price
$0.59
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.4K
6.3M
Earning Date
12-23-2025
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.10
52 Week High
$2.61
$10.69

Technical Indicators

Market Signals
Indicator
CCTG
PPCB
Relative Strength Index (RSI) 58.46 44.06
Support Level $0.39 N/A
Resistance Level $0.77 $0.13
Average True Range (ATR) 0.05 0.02
MACD 0.01 0.00
Stochastic Oscillator 76.32 21.08

Price Performance

Historical Comparison
CCTG
PPCB

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: